Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
Open Access
- 1 August 1992
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 90 (2), 456-461
- https://doi.org/10.1172/jci115881
Abstract
Recent observations in our laboratory suggest that angiotensin II (Ang II) is a bifunctional vascular smooth muscle cell (VSMC) growth modulator capable of inducing hypertrophy or inhibiting mitogen-stimulated DNA synthesis. Because transforming growth factor-beta 1 (TGF beta 1) has similar bifunctional effects on VSMC growth, we hypothesized that autocrine production of TGF beta 1 may mediate the growth modulatory effects of Ang II. Indeed, this study demonstrates that Ang II induces a severalfold increase in TGF beta 1 mRNA levels within 4 h that is dependent on de novo protein synthesis and appears to be mediated by activation of protein kinase C (PKC). Ang II not only stimulates the synthesis of latent TGF beta 1, but also promotes its conversion to the biologically active form as measured by bioassay. The coincubation of VSMCs with Ang II and control IgG has no significant mitogenic effect. However, the co-administration of Ang II and the anti-TGF beta 1 antibody stimulates significantly DNA synthesis and cell proliferation. We conclude that: (a) Ang II induces increased TGF beta 1 gene expression via a PKC dependent pathway involving de novo protein synthesis; (b) Ang II promotes the conversion of latent TGF beta 1 to its biologically active form; (c) Ang II modulates VSMC growth by activating both proliferative and antiproliferative pathways; and (d) Autocrine active TGF beta 1 appears to be an important determinant of VSMC growth by hypertrophy or hyperplasia.Keywords
This publication has 26 references indexed in Scilit:
- ACTIVATION OF THE 2ND PROMOTER OF THE TRANSFORMING GROWTH FACTOR-BETA-1 GENE BY TRANSFORMING GROWTH FACTOR-BETA-1 AND PHORBOL ESTER OCCURS THROUGH THE SAME TARGET SEQUENCES1989
- Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.The Journal of cell biology, 1989
- Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.The Journal of cell biology, 1989
- Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cellsJournal of Biological Chemistry, 1989
- Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.JCI Insight, 1989
- Fos and jun: The AP-1 connectionCell, 1988
- Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells.The Journal of cell biology, 1988
- Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.The Journal of cell biology, 1988
- Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.1987
- Binding of plasminogen to extracellular matrix.Journal of Biological Chemistry, 1986